Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers

  1. Hutchinson, K.E.
  2. Chen, J.W.
  3. Savage, H.M.
  4. Stout, T.J.
  5. Schimmoller, F.
  6. Cortés, J.
  7. Dent, S.
  8. Harbeck, N.
  9. Jacot, W.
  10. Krop, I.
  11. Trabucco, S.E.
  12. Sivakumar, S.
  13. Sokol, E.S.
  14. Wilson, T.R.
Revue:
Genome Medicine

ISSN: 1756-994X

Année de publication: 2023

Volumen: 15

Número: 1

Type: Article

DOI: 10.1186/S13073-023-01181-8 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus